Georg H. Waetzig
Kiel, SH 24118, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
A metabolic constraint in de novo NAD+ synthesis drives mucosal inflammation in IBD.
Journal: Journal of Crohn's & colitis
Published: June 01, 2026
Efficacy differentiation of sterile faecal filtrates in Clostridioides difficile infection.
Journal: The lancet. Gastroenterology & hepatology
Published: October 20, 2025
Oral Microcapsule Chromocolonoscopy With Patent Blue V Improves Adenoma Detection Safely and Effectively.
Journal: United European gastroenterology journal
Published: January 06, 2025
Cardiovascular safety of vitamin B3 administration.
Journal: Nature medicine
Published: March 15, 2024
Selective inhibition of IL-6 trans-signaling by a miniaturized, optimized chimeric soluble gp130 inhibits TH17 cell expansion.
Journal: Science signaling
Published: August 18, 2021
Case Report: Arterial Wall Inflammation in Atherosclerotic Cardiovascular Disease is Reduced by Olamkicept (sgp130Fc).
Journal: Frontiers in pharmacology
Published: August 13, 2021
Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease.
Journal: Gastroenterology
Published: August 27, 2020
Letter to the Editor: Non-specific effects resulting from use of tocilizumab in mice.
Journal: Metabolism: clinical and experimental
Published: May 19, 2020
Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cells.
Journal: PloS one
Published: January 08, 2020
The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes.
Journal: American journal of physiology. Endocrinology and metabolism
Published: June 26, 2019
Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
Journal: Gastroenterology
Published: February 28, 2019
Last Updated: 09/26/2026